Article
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.
Nature communications - 24 Feb 2017
Ju Huai-Qiang, Ying Haoqiang, Tian Tian, Ling Jianhua, Fu Jie, Lu Yu, Wu Min, Yang Lifeng, Achreja Abhinav, Chen Gang, Zhuang Zhuonan, Wang Huamin, Nagrath Deepak, Yao Jun, Hung Mien-Chie, DePinho Ronald A, Huang Peng, Xu Rui-Hua, Chiao Paul J
Abstract excerpt
Kras activation and p16 inactivation are required to develop pancreatic ductal adenocarcinoma (PDAC). However, the biochemical mechanisms underlying these double alterations remain unclear. Here we discover that NAD(P)H oxidase 4 (NOX4), an enzyme known to catalyse the oxidation of NAD(P)H, is upregulated when p16 is inactivated by looking at gene expression profiling studies. Activation of NOX4 requires...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.